1. Home
  2. RGTIW vs SNY Comparison

RGTIW vs SNY Comparison

Compare RGTIW & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rigetti Computing Inc.

RGTIW

Rigetti Computing Inc.

N/A

Current Price

$15.73

Market Cap

0.0

Sector

Technology

ML Signal

N/A

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$47.90

Market Cap

119.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGTIW
SNY
Founded
2013
1994
Country
United States
France
Employees
140
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
119.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RGTIW
SNY
Price
$15.73
$47.90
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$61.50
AVG Volume (30 Days)
850.8K
2.8M
Earning Date
03-11-2025
01-29-2026
Dividend Yield
N/A
3.32%
EPS Growth
N/A
105.93
EPS
N/A
8.67
Revenue
$11,892,000.00
$53,890,648,839.00
Revenue This Year
N/A
$2.48
Revenue Next Year
N/A
$6.47
P/E Ratio
N/A
$5.56
Revenue Growth
N/A
N/A
52 Week Low
$4.28
$44.62
52 Week High
$4.75
$60.12

Technical Indicators

Market Signals
Indicator
RGTIW
SNY
Relative Strength Index (RSI) 50.39 41.35
Support Level $11.00 $47.70
Resistance Level $13.80 $48.45
Average True Range (ATR) 2.17 0.65
MACD 0.24 -0.07
Stochastic Oscillator 59.82 31.80

Price Performance

Historical Comparison
RGTIW
SNY

About RGTIW Rigetti Computing Inc.

Rigetti Computing Inc is engaged in the business of full-stack quantum computing. The company offers full-stack quantum computing platform as a cloud service to a wide range of end-users, directly through its Rigetti QCS platform, and also through cloud service providers. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, the company derives the majority of its revenue from the United States.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: